Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ViAqua Therapeutics

Request full access

Developing an orally administered particle-based platform for the delivery of rna to improve resistance against diseases that attack shrimp and other aquaculture species

Haifa, IsraelFounded 2014Food

About ViAqua Therapeutics

ViAqua Therapeutics is a biotechnology startup that operates in the aquaculture industry, specifically focusing on the prevention of diseases in farmed shrimp. The company has developed an innovative oral delivery platform that uses encapsulated RNA particles to improve the resistance of shrimp and other aquaculture species to diseases. This is a significant breakthrough as there has been no effective method to prevent viral diseases in shrimp, which can wipe out an entire pond within 10 days.

ViAqua's business model revolves around the sale of its proprietary feed, which contains the RNA particles. This feed is sold to shrimp farmers worldwide, who are the primary clients of the company. The company operates in a global market, with the total value of the annual shrimp market being substantial. The market has also seen consistent growth over the past decade, indicating a promising future for the company.

The company's product not only enhances the health of the shrimp, reducing mortality from viral diseases such as White Spot Syndrome Virus (WSSV), but also addresses a significant gap in the aquaculture industry - health management. As the global population grows and the demand for food increases, effective health management in aquaculture is becoming increasingly important. ViAqua's solution offers a proven method of disease prevention, which is a key selling point for the company.

In summary, ViAqua Therapeutics is a promising biotech startup that has developed a unique solution to a significant problem in the aquaculture industry. The company's innovative approach to disease prevention in shrimp farming could potentially revolutionize the industry and contribute to global food security.

Source: Dealroom company data

ViAqua Therapeutics in the Haifa ecosystem

Live from Dealroom

The ViAqua Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A10 investors entered at this stage

  • Clay Capital
  • S2G Investments
  • Trendlines Group
  • Technion Israel Institute of Technology
  • Nutreco
  • Thai Union
  • Agriline
  • Rabo Ventures
  • I-Lab Angels
  • Full Circle Investments
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇮🇱 Israel81.8%
🇳🇱 Netherlands9.1%
🇨🇦 Canada9.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ViAqua Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ViAqua Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.